1 / 2

Global Regenerative Medicine Market Projects Greater Demand Owing to Higher Contribution by Leading Players

The Regenerative Medicine Market report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2026.<br>

susshree23
Download Presentation

Global Regenerative Medicine Market Projects Greater Demand Owing to Higher Contribution by Leading Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Regenerative Medicine Market Projects Greater Demand Owing to Higher Contribution by Leading Players during 2020-2025 The Regenerative Medicine Market report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2026. Growing chronic disorders across the globe, rising government funding regenerative medicine research and robust pipeline and products approval to drive the growth of the Regenerative medicine market Get Exclusive Sample of Report on Regenerative Medicine market at https://www.alltheresearch.com/sample-request/232 The global regenerative medicine market was valued at USD 13.56 billion in 2018 and is expected to reach USD 55.67 billion in 2026, growing at a CAGR of 19.4% during the forecast period. The global regenerative medicine market is expected to grow at a significant growth during the forecast period. The factors that are contributing to the growth of the market are growing chronic disorder across the globe coupled with growing research funding on genomic research. Genetic testing can determine the risk of cancer and others disease. According to the National Cancer Institute, in 2018, it is estimated that around 1,735,350 new cases of cancer will be diagnosed in the US. There has been a sudden increase in the RandD of cancer immunotherapies especially after the approval of the first checkpoint inhibitor in 2011. As a result, genomic research institutes have also enabled their research in the development of regenerative medicine for oncology. The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The Analyst team is meticulously tracking the impact and relevance to all the sectors in the Ecosystem. Key datasets include Revenue Impact analysis, Disruptions and New opportunities in the Supply Chain, Revised Vendor Landscape Mix, New opportunities mapping, and more. For More Details visit:https://www.alltheresearch.com/impactC19-request/232 Asia-Pacific is both a strong and promising market for regenerative medicine. This is particularly due to the strong population base, high prevalence of chronic diseases such as cancer and others in Asian countries such as China, Japan, and India. Half of the global incidence of cancer is projected to occur in Asia with 22% in China and 7% in India only that further provide the opportunity for market growth. According to NICPR (National Institute of Cancer Prevention and Research), India recorded 3.9 million cancer cases in 2016. Cancer is the major cause of deaths in the country. Poor economic conditions are supporting the number of deaths caused by cancer. Absence of proper diagnostic centres for the huge population is also the key contributing factor for the prevalence of cancer in the country. Key Findings: Based on type, the cell-based immunotherapy and cell therapy products segment is expected to grow at the highest CAGR of around 23% during the forecast period Based on application, the oncology segment is accounted for the largest share in the market and held for around 28% of the total market, in 2018

  2. North America accounted for around 45% share of the global regenerative medicine market in 2018 Inquire for Discount Upto 50% onRegenerative Medicine market 2019-26 Report at: https://www.alltheresearch.com/speak-to-analyst/232 Recent News: In 2018, Novartis International AG got the EU approval for one-time gene therapy Luxturna, which has been developed to restore vision in people with rare and genetically associated retinal disease. In 2018, Novartis International AG announced the approval from EU for its CAR-T cell Therapy named Kymriah In 2017, Integra LifeSciences announced the launch of Integra Dermal Regeneration Template Single Layer "Thin" for dermal repair defects reconstruction in a one-step procedure. TABLE OF CONTENT Chapter 1 Executive Summary Chapter 2 Market Dynamics Chapter 3 Global Regenerative Medicine Market, by Closing Mechanism Chapter 4 Global Regenerative Medicine Market, by Product Type Chapter 5 Global Regenerative Medicine Market, by Technology Chapter 6 Global Regenerative Medicine Market, by Region Chapter 7 Competitive Intelligence Chapter 8 Company Profiles Chapter 9 Preface Submit your details and specific interests for all customization needs Here https://www.alltheresearch.com/customization/232

More Related